TAK-632 (TAK632)

Chemical Structure : TAK-632

CAS No.: 1228591-30-7

加入收藏

货号: PC-72530Not For Human Use, Lab Use Only.

TAK-632 (TAK632) is a potent, selective pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF V600E and BRAF WT, respectively.

规格	价格	库存
5 mg	￥580	In stock
10 mg	￥880	In stock
25 mg	￥1380	In stock
50 mg	￥2180	In stock
100 mg		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

TAK-632 (TAK632) is a potent, selective pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF V600E and BRAF WT, respectively.
TAK-632 suppresses RAF activity in BRAF wild-type cells with minimal RAF paradoxical activation.
TAK-632 induces RAF dimerization but inhibits the kinase activity of the RAF dimer.
TAK-632 demonstrates potent antiproliferative effects both on NRAS-mutated melanoma cells and BRAF-mutated melanoma cells with acquired resistance to BRAF inhibitors through NRAS mutation or BRAF truncation.
TAK-632 exhibits synergistic antiproliferative effects combined with MEK inhibitor TAK-733.
TAK-632 also is a selective RIPK3 inhibitor (RIPK3 Kd =81 nM), > 60-fold selectivity against RIPK3 than RIPK1.

物理化学性质&存储条件

分子量	554.520
分子式	C27H18F4N4O3S
外观性状	Solid
CAS No.
储存条件	固体粉末 -20°C 12 个月; 4°C 6 个月	配置液 -80°C 6 个月; -20°C 6 个月
Shipping
Solubility	100 mM in DMSO (55.4 mg/mL)
Chemical Name/SMILES	N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide

参考文献

1. Nakamura A, et al. Cancer Res. 2013 Dec 1;73(23):7043-55.

2. Grasso M, et al. J Med Chem. 2018 Jun 14;61(11):5034-5046.

3. Chen X, et al. Br J Pharmacol. 2019 Jun;176(12):2095-2108.

4. Abt ER, et al. Cell Chem Biol. 2020 Feb 20;27(2):197-205.e6.

TAK-632 (TAK632)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

TAK-632 (TAK632)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

Get Quotation Now

* Indicates a Required FieldYour information is safe with us.